北京四环科宝制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
108
NMPA:108
Drug Approvals
Nicorandil for Injection
- Product Name
- 注射用尼可地尔
- Approval Number
- 国药准字H20247283
- Approval Date
- Nov 12, 2024
NMPA
Glutathione For Injection
- Product Name
- 注射用谷胱甘肽
- Approval Number
- 国药准字H20193296
- Approval Date
- Sep 10, 2024
NMPA
Rupatadine Fumarate Capsules
- Product Name
- 富马酸卢帕他定胶囊
- Approval Number
- 国药准字H20140096
- Approval Date
- Aug 22, 2024
NMPA
Olopatadine Hydrochloride Tablets
- Product Name
- 盐酸奥洛他定片
- Approval Number
- 国药准字H20237031
- Approval Date
- Aug 16, 2024
NMPA
Rupatadine Fumarate Tablets
- Product Name
- 富马酸卢帕他定片
- Approval Number
- 国药准字H20140097
- Approval Date
- Aug 12, 2024
NMPA
Olopatadine Hydrochloride Tablets
- Product Name
- 盐酸奥洛他定片
- Approval Number
- 国药准字H20143415
- Approval Date
- Jul 22, 2024
NMPA
Glutathione For Injection
- Product Name
- 注射用谷胱甘肽
- Approval Number
- 国药准字H20193297
- Approval Date
- Jul 22, 2024
NMPA
Vitamin E and C Chewable Tablets
- Product Name
- 维生素EC咀嚼片
- Approval Number
- 国药准字H20090356
- Approval Date
- Jul 22, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found